Á¶Çý¿¬ ±³¼ö
031-8086-2650
ºÎÀÎ¾Ï (³¼Ò¾Ï, ÀڱðæºÎ¾Ï, Àڱ󻸷¾Ï), ÀڱñÙÁ¾, ³¼Ò³¶Á¾, Àڱ󻸷Áõ, º¹°°æ¼ö¼ú, ·Îº¿¼ö¼ú, ´ÜÀÏ°ø ·Îº¿¼ö¼ú, Àڱó»½Ã°æ ¼ö¼ú
Áø·á½Ã°£ | ¿ù | È | ¼ö | ¸ñ | ±Ý | Åä |
---|---|---|---|---|---|---|
¿ÀÀü | ÈÞÁø | |||||
¿ÀÈÄ | ¿Ü·¡Áø·á | ¿Ü·¡Áø·á |
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷ ÇѸ²´ëÇб³ ÀϹݴëÇпø ÀÇÇаú ¼®»ç ¼¿ï´ëÇб³ ÀϹݴëÇпø ÀÇ°ú´ëÇÐ »êºÎÀΰúÇÐ ¹Ú»ç |
2007 ~ 2011ÇѸ²´ëÇб³°³²¼º½Éº´¿ø »êºÎÀΰú Àü°øÀÇ ¼ö·á 2011 ~ 2012ºÐ´ç¼¿ï´ëº´¿ø »êºÎÀΰú ºÎÀÎÁ¾¾çÇÐ ÀÓ»ó°»ç 2012 ~ 2014ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø »êºÎÀΰú ºÎÀÎÁ¾¾çÇÐ ÀÓ»ó°»ç 2014 ~ 2016ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø »êºÎÀΰú ÀÓ»óÁ¶±³¼ö 2016 ~ 2021ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø »êºÎÀΰú Á¶±³¼ö 2022 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø »êºÎÀΰú ºÎ±³¼ö |
´ëÇѺÎÀÎÁ¾¾çÇÐȸ ´ëÇÑ»êºÎÀΰúÇÐȸ À¯·´ ³»½Ã°æÇÐȸ ´ëÇÑ»êºÎÀΰú ·Îº¿¼ö¼úÇÐȸ ÆíÁýÀ§¿ø ´ëÇѺÎÀξÏÁß°³¿¬±¸È¸ ¿¬±¸ºÐ°úÀ§¿ø |
±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹® 1. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women. J Korean Med Sci. 2015 Dec;30(12):1777-83. 2. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics J Obstet Gynaecol Res. 2015 Dec 23. doi: 10.1111/jog.12915. [Epub ahead of print] 3. Detection of high-risk human papillomavirus using menstrual blood in women with high-grade squamous intraepithelial lesions or high-risk human papillomavirus infections: A pilot study J Obstet Gynaecol Res. 2015 Dec 2. doi: 10.1111/jog.12888. [Epub ahead of print] 4. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance. Anticancer Res. 2015 Jul;35(7):3909-16 5. Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons' Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer PLoS One. 2015 Jun 25;10(6):e0131170. 6. Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance. Obstet Gynecol Sci. 2015 Mar;58(2):117-23 7. Laparoscopic ovarian surgery in children and adolescents JSLS. 2015 Jan-Mar;19(1):e2014.00253. 8. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study. Med Sci Monit. 2014 Jul 30;20:1334-9 9. Surgical outcome and cost comparison between total vaginal hysterectomy and laparoscopic hysterectomy for uteri weighing >500 g J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):115-9 10. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma. Med Sci Monit. 2013 Mar 29;19:230-5 11. Prognostic significance of perineural invasion in cervical cancer. Int J Gynecol Pathol. 2013 Mar;32(2):228-33 12. Comparison of two bipolar systems in laparoscopic hysterectomy. JSLS. 2012 Jul-Sep;16(3):456-60 13. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology Arch Gynecol Obstet. 2012 Nov;286(5):1221-5 14. Endocervical margin involvement as an important risk factor for abnormal cytology after LLETZ. Int J Gynecol Pathol. 2012 Jul;31(4):377-81. 15. When do we need to perform laparotomy for benign uterine disease? Factors involved with conversion in vaginal hysterectomy J Obstet Gynaecol Res. 2012 Jan;38(1):31-4 16. Primary extranodal marginal zone B-cell lymphoma of MALT-type involving the fallopian tube. Gynecol Oncol Case Rep. 2011 Oct 30;2(1):6-8 17. Factors determining conversion to laparotomy in patients undergoing total laparoscopic hysterectomy. Gynecol Obstet Invest. 2011;71(3):193-7 18. Comparison of clinical effects between total vaginal hysterectomy and total laparoscopic hysterectomy on large uteruses over 300 grams. J Obstet Gynaecol Res. 2010 Jun;36(3):656-60 19. Anti-Mullerian Hormone Changes Following Laparoscopic Ovarian Cystectomy: A Prospective Comparative Study Int J Womens Health. 2021 Jul 12;13:691-6982. 20. Comparison of Postoperative Ovarian Reserve Function Following Laparoscopic Hysterectomy and Laparoscopic Myomectomy: A Prospective Comparative Pilot Study J Clin Med 2021 Jul 12;10(14):30773. 21. Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells. Cancer Res Treat. 2021 Jul;53(3):819-8284. 22. CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis. Med Sci Monit 2019 Feb 9;25:1087-1092 |